Technical Analysis for MEDXF - Medexus Pharmaceuticals Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Down | Down |
| Historical MEDXF trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -2.09% | |
| Oversold Stochastic | Weakness | -2.09% | |
| 50 DMA Resistance | Bearish | -5.71% | |
| NR7 | Range Contraction | -5.71% | |
| Inside Day | Range Contraction | -5.71% | |
| Wide Bands | Range Expansion | -5.71% | |
| Oversold Stochastic | Weakness | -5.71% | |
| 50 DMA Resistance | Bearish | -4.02% |
Get a Trading Assistant
Medexus Pharmaceuticals Inc Description
Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, which is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic spontaneous urticaria in patients 2 years of age and older. Its products portfolio also include Cuvposa, which is indicated for sialorrhea in patients aged 3-18 years with neurologic conditions, such as cerebral; Gliolan, an orally administered drug used for the visualization of various brain tumors; and Treosulfan, a conditioning agent used prior to stem cell transplantation. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Verdun, Canada.
Classification
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Keywords: Medical Specialties Clinical Medicine Pharmaceutical Immunology Arthritis Allergy Rheumatoid Arthritis Recombinant Transplantation Allergic Rhinitis Allergology Brain Tumor Rhinitis Trex Hemophilia Brain Tumors Dexus Immunosuppressants Medex Seasonal Allergic Rhinitis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.76 |
| 52 Week Low | 2.01 |
| Average Volume | 26,733 |
| 200-Day Moving Average | 0.0000 |
| 50-Day Moving Average | 5.9726 |
| 20-Day Moving Average | 6.3972 |
| 10-Day Moving Average | 5.8042 |
| Average True Range | 0.4555 |
| ADX | 25.3 |
| +DI | 16.9377 |
| -DI | 28.7103 |
| Chandelier Exit (Long, 3 ATRs ) | 6.3935 |
| Chandelier Exit (Short, 3 ATRs ) | 6.5865 |
| Upper Bollinger Band | 7.7274 |
| Lower Bollinger Band | 5.0670 |
| Percent B (%b) | 0.14 |
| BandWidth | 41.5869 |
| MACD Line | -0.1553 |
| MACD Signal Line | 0.0069 |
| MACD Histogram | -0.1622 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.1700 | ||||
| Resistance 3 (R3) | 6.1733 | 5.9367 | 6.0500 | ||
| Resistance 2 (R2) | 5.9367 | 5.7533 | 5.9350 | 6.0100 | |
| Resistance 1 (R1) | 5.6933 | 5.6400 | 5.5750 | 5.6900 | 5.9700 |
| Pivot Point | 5.4567 | 5.4567 | 5.3975 | 5.4550 | 5.4567 |
| Support 1 (S1) | 5.2133 | 5.2733 | 5.0950 | 5.2100 | 4.9300 |
| Support 2 (S2) | 4.9767 | 5.1600 | 4.9750 | 4.8900 | |
| Support 3 (S3) | 4.7333 | 4.9767 | 4.8500 | ||
| Support 4 (S4) | 4.7300 |
